全文获取类型
收费全文 | 2911篇 |
免费 | 161篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 93篇 |
妇产科学 | 71篇 |
基础医学 | 292篇 |
口腔科学 | 69篇 |
临床医学 | 256篇 |
内科学 | 693篇 |
皮肤病学 | 45篇 |
神经病学 | 228篇 |
特种医学 | 83篇 |
外科学 | 544篇 |
综合类 | 25篇 |
预防医学 | 175篇 |
眼科学 | 75篇 |
药学 | 170篇 |
中国医学 | 17篇 |
肿瘤学 | 238篇 |
出版年
2023年 | 23篇 |
2022年 | 45篇 |
2021年 | 87篇 |
2020年 | 59篇 |
2019年 | 94篇 |
2018年 | 78篇 |
2017年 | 60篇 |
2016年 | 74篇 |
2015年 | 77篇 |
2014年 | 89篇 |
2013年 | 133篇 |
2012年 | 146篇 |
2011年 | 159篇 |
2010年 | 92篇 |
2009年 | 75篇 |
2008年 | 117篇 |
2007年 | 131篇 |
2006年 | 93篇 |
2005年 | 85篇 |
2004年 | 95篇 |
2003年 | 83篇 |
2002年 | 93篇 |
2001年 | 72篇 |
2000年 | 81篇 |
1999年 | 64篇 |
1998年 | 25篇 |
1997年 | 18篇 |
1996年 | 17篇 |
1995年 | 22篇 |
1993年 | 14篇 |
1992年 | 73篇 |
1991年 | 57篇 |
1990年 | 55篇 |
1989年 | 67篇 |
1988年 | 66篇 |
1987年 | 68篇 |
1986年 | 62篇 |
1985年 | 52篇 |
1984年 | 36篇 |
1983年 | 22篇 |
1979年 | 29篇 |
1978年 | 14篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1975年 | 14篇 |
1972年 | 15篇 |
1971年 | 18篇 |
1970年 | 13篇 |
1969年 | 13篇 |
1968年 | 13篇 |
排序方式: 共有3083条查询结果,搜索用时 250 毫秒
101.
Fatemeh Gholami Sajjad Moradi Niloufar Rasaei Neda Soveid Leila Setayesh Khadijeh Mirzaei 《Journal of neurology》2022,269(1):205-216
Journal of Neurology - The Present study was conducted to systematically review the effect of the melatonin on sleep quality. We summarized evidence from randomized clinical trials (RCTs) that... 相似文献
102.
103.
Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Toru?MizuguchiEmail author Toshihiko?Torigoe Fukino?Satomi Hiroaki?Shima Goro?Kutomi Shigenori?Ota Masayuki?Ishii Hiroshi?Hayashi Sumiyo?Asakura Yoshihiko?Hirohashi Makoto?Meguro Yasutoshi?Kimura Toshihiko?Nishidate Kenji?Okita Masaho?Ishino Atsushi?Miyamoto Masamitsu?Hatakenaka Noriyuki?Sato Koichi?Hirata 《Surgery today》2016,46(2):139-148
Pancreatic tumors are chemoresistant and malignant, and there are very few therapeutic options for pancreatic cancer, as the disease is normally diagnosed at an advanced stage. Although attempts have been made to develop vaccine therapies for pancreatic cancer for a couple of decades, none of the resultant protocols or regimens have succeeded in improving the clinical outcomes of patients. We herein review vaccines tested within the past few years, including peptide, biological and multiple vaccines, and describe the three sets of criteria used to evaluate the therapeutic activity of vaccines in solid tumors. 相似文献
104.
Omar Barakat Martha N. Cagigas Shima Bozorgui Claire F. Ozaki R. Patrick Wood 《Journal of gastrointestinal surgery》2016,20(5):914-923
Background
Delayed gastric emptying (DGE) is a common complication of pancreaticoduodenectomy. We determined the efficiency of a new reconstruction technique, designed to preserve motilin-secreting cells and maximize the utility of their receptors, in reducing the incidence of DGE after pancreaticoduodenectomy.Methods
From April 2005 to September 2014, 217 consecutive patients underwent pancreaticoduodenectomy at our institution. Nine patients who underwent total pancreatectomy were excluded. We compared outcomes between patients who underwent pancreaticoduodenectomy with resection of the pyloric ring followed by proximal Roux-en-y gastrojejunal anastomosis (group I, n?=?90) and patients who underwent standard pancreaticoduodenectomy with the orthotopic reconstruction technique (group II, n?=?118).Results
Overall and clinically relevant rates of DGE were significantly lower in group I than in group II (10 and 2.2 % vs. 57 and 24 %, respectively; p?<?0.05). Length of hospital stay as a result of DGE was shorter in group I than in group II. In univariate analysis, older age, comorbidities, ASA grade 4, operative time, preoperative diabetes, standard reconstruction technique, and postoperative complications were significant risk factors for DGE. In multivariate analysis, older age, standard technique, and postoperative complications were independent risk factors for DGE.Conclusion
Our new reconstruction technique reduces the occurrence of DGE after pancreaticoduodenectomy.105.
Shima Gholizadeh Emmy M. Dolman Rebecca Wieriks Rolf W. Sparidans Wim E. Hennink Robbert J. Kok 《Pharmaceutical research》2018,35(4):85
Purpose
Sepantronium bromide (YM155) is a hydrophilic quaternary compound that cannot be administered orally due to its low oral bioavailability; it is furthermore rapidly eliminated via the kidneys. The current study aims at improving the pharmacokinetic profile of YM155 by its formulation in immunoliposomes that can achieve its enhanced delivery into tumor tissue and facilitate uptake in neuroblastoma cancer cells.Methods
PEGylated YM155 loaded liposomes composed of DPPC, cholesterol and DSPE-PEG2000 were prepared via passive film-hydration and extrusion method. Targeted (i.e. immuno-)liposomes were prepared by surface functionalization with SATA modified monoclonal anti-disialoganglioside (GD2) antibodies. Liposomes were characterized based on their size, charge, antibody coupling and YM155 encapsulation efficiency, and stability. Flow cytometry analysis and confocal microscopy were performed on IMR32 and KCNR neuroblastoma cell lines. The efficacy of developed formulations were assessed by in-vitro toxicity assays. A pilot pharmacokinetic analysis was performed to assess plasma circulation and tumor accumulation profiles of the developed liposomal formulations.Results
YM155 loaded immunoliposomes had a size of 170 nm and zeta potential of ?10 mV, with an antibody coupling efficiency of 60% andYM155 encapsulation efficiency of14%. Targeted and control liposomal formulations were found to have similar YM155 release rates in a release medium containing 50% serum. An in-vitro toxicity study on KCNR cells showed less toxicity for immunoliposomes as compared to free YM155. In-vivo pharmacokinetic evaluation of YM155 liposomes showed prolonged blood circulation and significantly increased half-lives of liposomal YM155 in tumor tissue, as compared to a bolus injection of free YM155.Conclusions
YM155 loaded immunoliposomes were successfully formulated and characterized, and initial in-vivo results show their potential for improving the circulation time and tumor accumulation of YM155.106.
107.
108.
Tatsuaki Sumiyoshi Yasuo Shima Ritsuo Nishiuchi Kiyoshi Sasaki Akihito Kouzuki Yoshihiro Noda Yasuhiro Hata Kiminobu Uka 《Surgery today》2014,44(6):1138-1141
A 13-year-old boy was referred to us for investigation of a giant liver mass, approximately 16 cm in diameter. Sonographically guided percutaneous needle biopsy was performed and histological examination revealed a fetal-type hepatoblastoma. After four courses of chemotherapy, we performed a left hepatic trisegmentectomy. Follow-up computed tomography, 55 months after the surgery, showed a 1-cm tumor on the route of the preoperative needle biopsy. A second laparotomy revealed a peritonealised tumor, which was excised. The histology of this tumor was identical to that of the primary hepatoblastoma. To our knowledge, this is only the second report of needle tract implantation of hepatoblastoma after percutaneous needle biopsy. 相似文献
109.
110.
Stephen M.F. Jamieson Yongchuan Gu Donya Moradi Manesh Jad El-Hoss Duohui Jing Karen L. MacKenzie Christopher P. Guise Annika Foehrenbacher Susan M. Pullen Juliana Benito Jeffrey B. Smaill Adam V. Patterson Medhanie A. Mulaw Marina Konopleva Stefan K. Bohlander Richard B. Lock William R. Wilson 《Biochemical pharmacology》2014
Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) metabolises steroid hormones, prostaglandins and xenobiotics, and activates the dinitrobenzamide mustard prodrug PR-104A by reducing it to hydroxylamine PR-104H. Here, we describe a functional assay for AKR1C3 in cells using the fluorogenic probe coumberone (a substrate for all AKR1C isoforms) in conjunction with a specific inhibitor of AKR1C3, the morpholylurea SN34037. We use this assay to evaluate AKR1C3 activity and PR-104A sensitivity in human leukaemia cells. SN34037-sensitive reduction of coumberone to fluorescent coumberol correlated with AKR1C3 protein expression by immunoblotting in a panel of seven diverse human leukaemia cell lines, and with SN34037-sensitive reduction of PR-104A to PR-104H. SN34037 inhibited aerobic cytotoxicity of PR-104A in high-AKR1C3 TF1 erythroleukaemia cells, but not in low-AKR1C3 Nalm6 pre-B cell acute lymphocytic leukaemia (B-ALL) cells, although variation in PR-104H sensitivity confounded the relationship between AKR1C3 activity and PR-104A sensitivity across the cell line panel. AKR1C3 mRNA expression showed wide variation between leukaemia patients, with consistently higher levels in T-ALL than B-ALL. In short term cultures from patient-derived paediatric ALL xenografts, PR-104A was more potent in T-ALL than B-ALL lines, and PR-104A cytotoxicity was significantly inhibited by SN34037 in T-ALL but not B-ALL. Overall, the results demonstrate that SN34037-sensitive coumberone reduction provides a rapid and specific assay for AKR1C3 activity in cells, with potential utility for identifying PR-104A-responsive leukaemias. However, variations in PR-104H sensitivity indicate the need for additional biomarkers for patient stratification. 相似文献